| Financial Year |
March 31 2023 |
| Monetary Funds |
326,408,982.12 |
| Held-for-trading Financial Assets |
166,046,991.00 |
| Notes Receivable |
24,629,673.86 |
| Accounts Receivable |
160,277,191.56 |
| Advances to Suppliers |
16,689,040.86 |
| Other Receivables |
7,096,714.12 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
174,774,377.99 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
6,944,569.94 |
| Total Current Assets |
907,668,526.39 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
45,460,801.44 |
| Investment Properties |
-- |
| Fixed Assetes |
510,261,462.23 |
| Under-construction Projects |
84,531,227.17 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
27,004,744.08 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
4,076,421.41 |
| Deferred Income Tax Assets |
2,130,717.81 |
| Other Non-Current Assets |
32,126,892.59 |
| Sub-Total of Non-Current Assets |
708,973,448.41 |
| Total Assets |
1,616,641,974.80 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
10,364,663.76 |
| Accounts Payable |
101,217,548.11 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
13,507,407.09 |
| Taxes Payable |
1,692,839.59 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
4,141,218.92 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
419,369.37 |
| Other Current Liabilities |
7,255,949.38 |
| Sub-Total of Current Liabilities |
150,494,560.67 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
9,272,840.65 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
11,987,909.52 |
| Total Liabilities |
162,482,470.19 |
| Paid-In Capital(Or Share Stock) |
232,410,000.00 |
| Capital Surplus |
797,867,367.85 |
| Surplus Reserve |
64,693,020.36 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
359,189,116.40 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,454,159,504.61 |
| Owner's Equity（Stockholder's Equity） |
1,454,159,504.61 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,616,641,974.80 |
